Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first281 to 300 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| ITGAX integrin subunit alpha X | 3687 HGNC:6152 | 1 | 73 | 0 | 0 | 14,179 | 23,134 |
| LDLR low density lipoprotein receptor | 3949 HGNC:6547 | 1 | 171 | 0 | 0 | 9,840 | 23,071 |
| CD40LG CD40 ligand | 959 HGNC:11935 | 1 | 708 | 6 | 26 | 10,045 | 23,000 |
| TIMP1 TIMP metallopeptidase inhibitor 1 | 7076 HGNC:11820 | 1 | 210 | 0 | 0 | 7,599 | 22,927 |
| MT-CO1 mitochondrially encoded cytochrome c oxidase I | 4512 HGNC:7419 | 1 | 26 | 0 | 0 | 6,404 | 22,901 |
| PRKAA2 protein kinase AMP-activated catalytic subunit alpha 2 | 5563 HGNC:9377 | 1 | 35 | 1 | 2 | 8,141 | 22,848 |
| VDR vitamin D receptor | 7421 HGNC:12679 | 1 | 113 | 19 | 866 | 7,369 | 22,845 |
| BMP2 bone morphogenetic protein 2 | 650 HGNC:1069 | 1 | 274 | 0 | 0 | 6,741 | 22,793 |
| IL1RN interleukin 1 receptor antagonist | 3557 HGNC:6000 | 1 | 301 | 0 | 0 | 9,627 | 22,780 |
| DES desmin | 1674 HGNC:2770 | 1 | 27 | 0 | 0 | 4,909 | 22,779 |
| HLA-DRB1 major histocompatibility complex, class II, DR beta 1 | 3123 HGNC:4948 | 1 | 67 | 3 | 9 | 7,645 | 22,691 |
| VTN vitronectin | 7448 HGNC:12724 | 1 | 149 | 0 | 0 | 7,874 | 22,578 |
| FLT3 fms related receptor tyrosine kinase 3 | 2322 HGNC:3765 | 1 | 147 | 47 | 1,466 | 7,394 | 22,539 |
| SP1 Sp1 transcription factor | 6667 HGNC:11205 | 1 | 54 | 0 | 0 | 11,247 | 22,521 |
| RAC1 Rac family small GTPase 1 | 5879 HGNC:9801 | 1 | 146 | 0 | 0 | 11,328 | 22,375 |
| LIPC lipase C, hepatic type | 3990 HGNC:6619 | 1 | 57 | 0 | 0 | 8,168 | 22,281 |
| PLAU plasminogen activator, urokinase | 5328 HGNC:9052 | 1 | 32 | 1 | 16 | 6,100 | 22,244 |
| HBB hemoglobin subunit beta | 3043 HGNC:4827 | 1 | 181 | 4 | 27 | 9,397 | 22,237 |
| SMAD4 SMAD family member 4 | 4089 HGNC:6770 | 1 | 98 | 0 | 0 | 8,274 | 22,156 |
| DNMT1 DNA methyltransferase 1 | 1786 HGNC:2976 | 1 | 36 | 2 | 1,212 | 9,316 | 22,131 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=15
{
"data": {
"total": 193990,
"results": [
{
"id": "3687",
"title": "ITGAX: integrin subunit alpha X",
"summary": "NCBI Gene 3687. 1 protein, 73 patents, 0 drugs, 0 trials, 14,179 NIH grants and 23,134 papers.",
"record": "/library/genes/3687",
"gene_id": 3687,
"symbol": "ITGAX",
"name": "integrin subunit alpha X",
"hgnc_id": "HGNC:6152",
"counts": {
"proteins": 1,
"patents": 73,
"drugs": 0,
"trials": 0,
"grants": 14179,
"papers": 23134
}
},
{
"id": "3949",
"title": "LDLR: low density lipoprotein receptor",
"summary": "NCBI Gene 3949. 1 protein, 171 patents, 0 drugs, 0 trials, 9,840 NIH grants and 23,071 papers.",
"record": "/library/genes/3949",
"gene_id": 3949,
"symbol": "LDLR",
"name": "low density lipoprotein receptor",
"hgnc_id": "HGNC:6547",
"counts": {
"proteins": 1,
"patents": 171,
"drugs": 0,
"trials": 0,
"grants": 9840,
"papers": 23071
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=16",
"request_id": "MNCs3DuYa9Caravb"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant